264 related articles for article (PubMed ID: 14502678)
1. Botulinum toxin B reduces sialorrhea in parkinsonism.
Racette BA; Good L; Sagitto S; Perlmutter JS
Mov Disord; 2003 Sep; 18(9):1059-61. PubMed ID: 14502678
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
Su CS; Lan MY; Liu JS; Chang CC; Lai SL; Wu HS; Chen SS; Chang YY
Acta Neurol Taiwan; 2006 Sep; 15(3):170-6. PubMed ID: 16995596
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin for treatment of parkinsonian sialorrhea.
Friedman A; Potulska A
Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
Verma A; Steele J
Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
[TBL] [Abstract][Full Text] [Related]
6. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
Turk-Gonzales M; Odderson IR
Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin injections for children with excessive drooling.
Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
[TBL] [Abstract][Full Text] [Related]
9. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
10. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
Fuster Torres MA; Berini Aytés L; Gay Escoda C
Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
[TBL] [Abstract][Full Text] [Related]
11. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients.
Jackson CE; Gronseth G; Rosenfeld J; Barohn RJ; Dubinsky R; Simpson CB; McVey A; Kittrell PP; King R; Herbelin L;
Muscle Nerve; 2009 Feb; 39(2):137-43. PubMed ID: 19145653
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
Tan EK
Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease.
Contarino MF; Pompili M; Tittoto P; Vanacore N; Sabatelli M; Cedrone A; Rapaccini GL; Gasbarrini G; Tonali PA; Bentivoglio AR
Parkinsonism Relat Disord; 2007 Jul; 13(5):299-303. PubMed ID: 16807056
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.
Steinlechner S; Klein C; Moser A; Lencer R; Hagenah J
Psychopharmacology (Berl); 2010 Jan; 207(4):593-7. PubMed ID: 19823807
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C; Beuche W
Laryngoscope; 2002 Jan; 112(1):82-6. PubMed ID: 11802043
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of sialorrhea with botulinum toxin].
Jost WH; Bäumer T; Laskawi R; Spittau B; Steffen A; Winterholler M
Fortschr Neurol Psychiatr; 2019 Oct; 87(10):554-563. PubMed ID: 31344747
[TBL] [Abstract][Full Text] [Related]
20. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
